536 related articles for article (PubMed ID: 32849525)
1. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
2. Host-directed therapy targeting the Mycobacterium tuberculosis granuloma: a review.
Kiran D; Podell BK; Chambers M; Basaraba RJ
Semin Immunopathol; 2016 Mar; 38(2):167-83. PubMed ID: 26510950
[TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
4. New approaches to tuberculosis--novel drugs based on drug targets related to toll-like receptors in macrophages.
Tomioka H
Curr Pharm Des; 2014; 20(27):4404-17. PubMed ID: 24245765
[TBL] [Abstract][Full Text] [Related]
5. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
6. The antibiotic bedaquiline activates host macrophage innate immune resistance to bacterial infection.
Giraud-Gatineau A; Coya JM; Maure A; Biton A; Thomson M; Bernard EM; Marrec J; Gutierrez MG; Larrouy-Maumus G; Brosch R; Gicquel B; Tailleux L
Elife; 2020 May; 9():. PubMed ID: 32369020
[TBL] [Abstract][Full Text] [Related]
7. Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.
Kramnik I; Beamer G
Semin Immunopathol; 2016 Mar; 38(2):221-37. PubMed ID: 26542392
[TBL] [Abstract][Full Text] [Related]
8. Macrophage defense mechanisms against intracellular bacteria.
Weiss G; Schaible UE
Immunol Rev; 2015 Mar; 264(1):182-203. PubMed ID: 25703560
[TBL] [Abstract][Full Text] [Related]
9. Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches.
Al-Ghafli H; Al-Hajoj S
Curr Pharm Biotechnol; 2019; 20(4):272-284. PubMed ID: 30062961
[TBL] [Abstract][Full Text] [Related]
10. Mycobacteria, metals, and the macrophage.
Neyrolles O; Wolschendorf F; Mitra A; Niederweis M
Immunol Rev; 2015 Mar; 264(1):249-63. PubMed ID: 25703564
[TBL] [Abstract][Full Text] [Related]
11. Natural and trained innate immunity against Mycobacterium tuberculosis.
Ferluga J; Yasmin H; Al-Ahdal MN; Bhakta S; Kishore U
Immunobiology; 2020 May; 225(3):151951. PubMed ID: 32423788
[TBL] [Abstract][Full Text] [Related]
12. Cell death at the cross roads of host-pathogen interaction in Mycobacterium tuberculosis infection.
Mohareer K; Asalla S; Banerjee S
Tuberculosis (Edinb); 2018 Dec; 113():99-121. PubMed ID: 30514519
[TBL] [Abstract][Full Text] [Related]
13. Host-Directed Therapeutics as a Novel Approach for Tuberculosis Treatment.
Kim YR; Yang CS
J Microbiol Biotechnol; 2017 Sep; 27(9):1549-1558. PubMed ID: 28683527
[TBL] [Abstract][Full Text] [Related]
14. Modulating Iron for Metabolic Support of TB Host Defense.
Phelan JJ; Basdeo SA; Tazoll SC; McGivern S; Saborido JR; Keane J
Front Immunol; 2018; 9():2296. PubMed ID: 30374347
[TBL] [Abstract][Full Text] [Related]
15. Host-Directed Therapies: Modulating Inflammation to Treat Tuberculosis.
Krug S; Parveen S; Bishai WR
Front Immunol; 2021; 12():660916. PubMed ID: 33953722
[TBL] [Abstract][Full Text] [Related]
16. Interaction of Mycobacterium tuberculosis with the host: consequences for vaccine development.
Dietrich J; Doherty TM
APMIS; 2009 May; 117(5-6):440-57. PubMed ID: 19400867
[TBL] [Abstract][Full Text] [Related]
17. Introduction.
Kaufmann SH
Semin Immunol; 2014 Dec; 26(6):429-30. PubMed ID: 25459522
[No Abstract] [Full Text] [Related]
18. Predicting the Outcomes of New Short-Course Regimens for Multidrug-Resistant Tuberculosis Using Intrahost and Pharmacokinetic-Pharmacodynamic Modeling.
Doan TN; Cao P; Emeto TI; McCaw JM; McBryde ES
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249697
[TBL] [Abstract][Full Text] [Related]
19. Targeting immunometabolism in host defence against Mycobacterium tuberculosis.
Sheedy FJ; Divangahi M
Immunology; 2021 Feb; 162(2):145-159. PubMed ID: 33020911
[TBL] [Abstract][Full Text] [Related]
20. The
Sharma T; Alam A; Ehtram A; Rani A; Grover S; Ehtesham NZ; Hasnain SE
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
